Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
The components of loss before income taxes are as follows: 
 
 
 
Year Ended December 31,
 
 
 
2018
 
 
2017
 
Domestic
 
$
(11,242,646
)
 
$
(15,102,521
)
Foreign
 
 
517,268
 
 
 
542,631
 
Total
 
$
(10,725,378
)
 
$
(14,559,890
)
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
The components of income tax benefit are as follows: 
 
 
 
Year Ended December 31,
 
 
 
2018
 
 
2017
 
Deferred Taxes:
 
 
 
 
 
 
 
 
Federal
 
$
1,814
 
 
$
(1,160,312
)
State
 
 
84,231
 
 
 
(181,661
)
Total Deferred Taxes
 
$
86,045
 
 
$
(1,341,973
)
Income Tax Expense (Benefit)
 
$
86,045
 
 
$
(1,341,973
)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
The difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined by applying the applicable statutory U.S. tax rate are analyzed below:
 
 
 
Year Ended December 31,
 
 
 
2018
 
 
2017
 
United States Federal Income Tax Rate
 
 
21.00
%
 
 
34.00
%
State Taxes, Net of Federal Benefit
 
 
(0.38
)
 
 
4.68
 
Permanent Differences
 
 
(1.48
)
 
 
(2.67
)
Change in Valuation Allowance
 
 
3.88
 
 
 
46.88
 
Research and Development Credits
 
 
1.06
 
 
 
1.97
 
Tax Rate Differential
 
 
(1.33
)
 
 
0.01
 
Federal Rate Change
 
 
0.00
 
 
 
(71.74
)
Topic 606 Adoption
 
 
(20.90
)
 
 
0.00
 
Other
 
 
(2.65
)
 
 
(3.91
)
Effective Tax Rate (Expense) Benefit
 
 
(0.80
)%
 
 
9.22
%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
The Company’s deferred tax assets and liabilities consist of the following: 
 
 
 
Year Ended December 31,
 
 
 
2018
 
 
2017
 
Net Deferred Tax Liability:
 
 
 
 
 
 
 
 
Net Operating Loss Carryforwards
 
$
13,601,705
 
 
$
12,624,253
 
Research and Development Credit Carryforwards
 
 
2,124,949
 
 
 
2,002,640
 
Capitalized Research and Development
 
 
5,861,675
 
 
 
5,172,541
 
Nonqualified Stock Option
 
 
639,729
 
 
 
552,096
 
Depreciation and Amortization
 
 
(3,217
)
 
 
(82
)
Cash Versus Accrual Adjustments
 
 
2,069,985
 
 
 
4,459,785
 
Total Deferred Tax Assets
 
 
24,294,826
 
 
 
24,811,233
 
Valuation Allowance
 
 
(23,659,844
)
 
 
(24,075,539
)
Net Deferred Tax Asset
 
 
634,982
 
 
 
735,694
 
In-Process Research and Development
 
 
(904,950
)
 
 
(919,617
)
Net Deferred Tax Liability
 
$
(269,968
)
 
$
(183,923
)